Monitoring and Preemptive Rituximab Therapy for Epstein-Barr Virus Reactivation after Antithymocyte Globulin Containing Nonmyeloablative Conditioning for Umbilical Cord Blood Transplantation
Open Access
- 28 February 2010
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 16 (2), 287-291
- https://doi.org/10.1016/j.bbmt.2009.10.008
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (PO1-CA65493)
- Children's Cancer Research Fund
This publication has 24 references indexed in Scilit:
- Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell TransplantationTransplantation, 2009
- Ex Vivo Expansion and Th1/Tc1 Maturation of Umbilical Cord Blood T Cells by CD3/CD28 CostimulationTransplantation and Cellular Therapy, 2008
- Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trialBlood, 2007
- Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantationBlood, 2006
- Increased incidence of EBV‐related disease following paediatric stem cell transplantation with reduced‐intensity conditioningBritish Journal of Haematology, 2005
- Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioningBlood, 2003
- Pre-emptive therapy with rituximab for prevention of Epstein–Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantationBone Marrow Transplantation, 2003
- Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipientsTransplantation and Cellular Therapy, 2001
- Early intervention in post-transplant lymphoproliferative disorders based on Epstein–Barr viral loadBone Marrow Transplantation, 2000
- B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcomeBone Marrow Transplantation, 1999